More Missing MIs, Late Complications Blamed on COVID-19 in Italy and California
As data come in from big hospital networks and across countries, physicians are urging health administrators to learn the lessons.
As data come in from big hospital networks and across countries, physicians are urging health administrators to learn the lessons.
Compared with cold storage, the organ-preservation system helped posttransplant outcomes despite longer ischemic times.
Prevention of stroke gets highlighted by guidelines and is top-of-mind for patients, but heart failure is much more common.
Just under 50% of those treated surgically were taking no antihypertensives, all while maintaining good BP control.
Already products are entering the market, and if found to improve outcomes, they may become standard of care.
Physicians have adopted a one-size-fits-all approach to direct oral anticoagulants that must be reconsidered, says Geoffrey Barnes.
A diagnosis can provide patients with better understanding as well as a chance to receive targeted treatment, Colin Berry says.
Investigators and others think it might be time for everybody in the US to have their Lp(a) screened at least once in a lifetime.
Top-line findings from the SURMOUNT-OSA trials may have implications for cardiometabolic risks in this population.
Jeffrey Carson and Serge Korjian discuss restrictive versus liberal blood transfusion in patients with MI and anemia.
Initial safety and efficacy findings from this first-in-human series “look really impressive,” but experts await further studies.